Bigul

Covaxin gets emergency use approval in the 2-18 age group

Bharat Biotech's antidote will be the second vaccine for children after Zydus' ZyCov-D
12-10-2021
Bigul

Zydus Wellness Ltd - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of Compliance under Regulation 39(3) of Details of Loss of Certificate.
11-10-2021
Bigul

ZYDUS WELLNESS LTD.-$ - 531335 - Shareholding for the Period Ended September 30, 2021

Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
07-10-2021
Bigul

ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Compliance Intimation under Regulation 39(3) for details of loss of share certificate.
07-10-2021
Bigul

Zydus Wellness Ltd - 531335 - Statement Of Investor Complaints For The Quarter Ended September 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dhanraj P DagarDesignation :- Company Secretary and Compliance Officer
05-10-2021
Bigul

ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.
05-10-2021
Bigul

DCGI approves Phase 3 trial of Zydus' two-dose vaccine

The development comes in the backdrop of Zydus presenting a revised clinical trial protocol
04-10-2021

Zydus' antibody cocktail, Glenmark's nasal spray among 20 drugs in the pipeline to fight COVID-19

While the market for these drugs may not be huge at present due to a drop in Covid-19 cases and extended timelines, experts believe that these drugs will help control future waves and protect people with weak immunity.
02-10-2021
Bigul

Zydus Wellness Ltd - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of details of loss of certificate under regulation 39(3) of LODR.
02-10-2021

3-dose Zydus vaccine to be included in Covid vaccination programme: Govt

Sixty-nine per cent of the country's adult population has received at least one dose of Covid-19 vaccine and 25% has taken both doses, the government said on Thursday.
30-09-2021
Next Page
Close

Let's Open Free Demat Account